Texas § 489.051 PATIENT ELIGIBILITY.

Texas Statutes

§ 489.051 — PATIENT ELIGIBILITY.

Texas § 489.051

Code HSHealth and Safety Code

This text of Texas § 489.051 (PATIENT ELIGIBILITY.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Health and Safety Code Code Ann. § 489.051 (2026).

Text

Sec. 489.051. PATIENT ELIGIBILITY. A patient is eligible to access and use an investigational drug, biological product, or device under this chapter if:

(1)the patient has a terminal illness, attested to by the patient's treating physician; and

(2)the patient's physician:

(A)in consultation with the patient, has considered all other treatment options currently approved by the United States Food and Drug Administration and determined that those treatment options are unavailable or unlikely to prolong the patient's life; and

(B)has recommended or prescribed in writing that the patient use a specific class of investigational drug, biological product, or device.

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 489.051. PATIENT ELIGIBILITY. A patient is eligible to access and use an investigational drug, biological product, or device under this chapter if:
(1) the patient has a terminal illness, attested to by the patient's treating physician; and
(2) the patient's physician:
(A) in consultation with the patient, has considered all other treatment options currently approved by the United States Food and Drug Administration and determined that those treatment options are unavailable or unlikely to prolong the patient's life; and
(B) has recommended or prescribed in writing that the patient use a specific class of investigational drug, biological product, or device.